Abstract: Suicidal behavior (SB) is characterized by the occurrence of suicide attempts with substantial intent to die. SB is a major health problem worldwide. In the great majority of cases, SB occurs in patients suffering from psychiatric disorders, mainly from affective disorders or schizophrenia. Despite this high association, there is growing evidence from genetic studies that SB might represent a psychiatric condition on its own. This review provides an overview of the most significant neurobiological and neurocognitive findings in SB. We provide evidence for specific dysfunctions within the serotonergic system, for distinct morphological abnormalities in the gray and white matter composition as well as for neurofunctional alterations in the fronto-striatal network. Additionally, the putative role of impulsivity and hopelessness as trait-like risk factors for SB is outlined. Both the personality traits are associated with altered prefrontal cortex function and deficits in cognitive and affective control similar to the findings in SB. Given the difficulties of clinical risk assessment, there is a need to identify specific markers that can predict SB more reliably. Some recent neurocognitive and functional/structural neuroimaging findings might be appropriate to use as SB indicators in the close future.
Introduction
Suicide is one of the most frequent causes of unnatural death. According to the United Nations, 1 more people die by suicide every year than by both homicide and war. About one million suicides and ten million suicide attempts occur worldwide each year, representing a mortality rate of 14.5 deaths per 100,000 habitants per year. 2 More than 90% of all suicide completers suffer from mental illness, most commonly from mood disorders. 3, 4 Major depressive disorder (MDD) is a common and highly debilitating condition, which affects approximately one in ten people in Europe. 5 The risk of suicide is 17 times higher in people with mood disorders than in the general population.
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Sobanski et al strong need for additional tests predicting SB more reliably. Nock et al 10 reported that implicit cognition of death and suicide as measured by a computer-administered neurocognitive paradigm exceeded the predictive validity of known risk factors (eg, depression, suicide-attempt history) and clinicians' predictions. In the near future, even more precise estimates may become possible by the use of structural and functional neuroimaging approaches providing markers of an increased suicide risk. 11, 12 During the last two decades, a variety of studies have been published on neurobiological and neurofunctional alterations in SB. The aim of this review is to provide a comprehensive overview on most significant findings. An exhaustive presentation of the research is barely possible and certainly beyond the scope of this work.
Theoretical concept of SB
SB is a complex and multifaceted phenomenon with several state-and trait-dependent factors. A stress-diathesis model has been introduced by Mann 4 to describe the potential interaction between risk factors for suicidal ideation (SI) and SB. In this paper, we focused on SB, which is a more circumscribed construct when compared to SI. Therefore, we propose a "diathesis-stress model" as shown in Figure 1 . According to this model, hopelessness and impulsivity are considered as trait-like components of the diathesis for SB, while acute psychiatric disorders such as MDD or psychosocial crises are considered as state-dependent stressors. The concepts of impulsivity and hopelessness and their neurobiological correlates will be discussed in more detail in the subsequent sections.
With regard to potential animal models of SB, no convincing animal models have been constructed to date. Preti 13 stated in his review that despite the investigation of thousands of animals, suicide in nonhuman species has not been observed in nature. Therefore, the current animal research is focusing on similar endophenotypes of SB as proposed in the current human research, ie, hopelessness ("learned helplessness" in the animal research) and impulsivity/ aggression. 13 The presentation of the animal research findings is, however, beyond the scope of this work.
Genetic factors in SB
Twin studies have revealed higher concordance rate for suicide in monozygotic than dizygotic twins (24.1% vs 2.8%).
14 In adoption studies, suicide rates are fourfold to sixfold higher in the biological relatives of adoptees who die by suicide compared with adoptive relatives. 15 Family studies in patients with MDD have shown that predisposition to SB is transmitted independent of the psychiatric disorder. 8 The heritability of SB is high, about 30%-50% for a broad definition of suicidality that includes ideation and plans 16 and approximately 55% for serious suicide attempts. 17 Given this evidence, it has been proposed that SB in patients with MDD might represent a separate nosological (sub-)entity which might be independent of MDD itself. 16, 18 However, considering the fact that SB is a highly complex human behavior, genetic effects are believed to act through intermediate phenotypes, which are conceptualized as mediators between genes and SB. 19 There are considerable data suggesting that impulsive-aggressive personality traits may act as such an intermediate phenotype of SB. 8 Dumais et al 20 and McGirr et al 21 reported that higher levels of impulsive behavior were related to increased suicide risk among patients with the same psychiatric diagnosis, such as major depression. Furthermore, Kim et al 22 observed that familial aggregation of SB co-segregates with familial transmission of impulsive-aggressive behavior.
Neurobiological evidence implicates serotonergic dysfunction in SB as well as in impulse control disorder. For instance, Lidberg et al 23 observed low cerebrospinal fluid (CSF) levels of a serotonin metabolite (5-hydroxyindoleacetic acid) in suicide attempters as well as in mentally ill violent offenders. Research has therefore focused on the association between SB and various serotonergic genes (tryptophan hydroxylase [TPH] genes TPH1 and TPH2; serotonin transporter gene with functional promoter polymorphism 5-HTTLPR; serotonin receptor genes HTR1A, HTR2A, HTR1B, HTR2C, and monoamine oxidase A [MAOA] gene). Several studies report associations between SB and variation on the TPH1 gene 24 and between SB and 5-HTTLPR promoter polymorphism in the serotonin transporter gene. 25, 26 With regards to the TPH2 gene and serotonin receptor genes, results are inconsistent. Studies on endophenotypes 
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Neural, cognitive, and neuroimaging markers of the suicidal brain of suicidality, such as aggression and impulsive behavior, showed positive associations for the TPH1, HTR2A, and MAOA genes, 27 but further replication of these findings is necessary.
Neurochemical abnormalities associated with SB
The majority of studies on the neurobiology of SB reported neurochemical alterations of the serotonergic system. As already stated in the previous paragraph low serotonin turnover in the central nervous system in SB is among the most robust findings. 28 In contrast, there are no consistent changes regarding dopamine or norepinephrine metabolites. 29 Serotonin is synthesized exclusively in nuclei in the brainstem, the dorsal and median raphe nuclei (DRN and MRN) . Abnormal function of DRN and MRN in SB is a wellestablished fact. 4 Stockmeier et al 30 reported an increase in the binding of a selective 5-hydroxytryptamine 1A (5-HT 1A ) agonist 3H-8-hydroxy-2-(N-dipropylamino)tetralin ([3H]8-OH-DPAT) to serotonin-1A receptors in the DRN in suicide victims with MDD, indicating diminished serotonergic activity. Similarly, postmortem neuronal TPH2 expression in the DRN has been observed to be increased in suicide victims with MDD, 31, 32 which has been interpreted as a compensatory mechanism to a reduction in serotonergic transmission in both cortical and subcortical regions of depressed patients who committed suicide. Indeed, decreased serotonin transporter (5-Hydroxytryptamintransporter ) binding in the midbrain, 33, 34 pons, basal ganglia, 35 and cerebellum 36 was also reported in in vivo studies of suicide attempters.
The DRN and MRN give rise to ascending projections to the thalamus and other subcortical and cortical brain regions. In recent research of the serotonergic system in SB, the prefrontal cortex (PFC) has attracted considerable attention. Due to its putatively significant role in SB, studies with various methodological approaches have focused on the PFC and have shown alterations in this region. Postmortem studies in suicide victims reported increased postsynaptic 5-HT1A and 5-HT2A receptor binding in PFC, 37 and in particular a reduction in serotonin transporter binding in ventromedial PFC (VMPFC) 38 and ventrolateral PFC (VLPFC), 39 indicating a potential compensatory mechanism of low serotonergic neuron activity. Audenaert et al 40 investigated suicide attempters in vivo and found reduced 5-HT2A receptor binding in the bilateral frontal cortex, mainly in the dorsolateral PFC (DLPFC). In addition, the authors described a negative correlation between binding intensity and both hopelessness and harm avoidance. Leyton et al 41 reported reduced alpha-[11C]methyl-l-tryptophan trapping indicating decreased serotonin synthesis in the orbitofrontal cortex (OFC) and VMPFC in high-lethality suicide attempters. Moreover, there was a negative correlation between suicidal intent and alpha-[11C]methyl-l-tryptophan trapping in these regions. The authors concluded that low serotonin synthesis in the medial PFC may lower the threshold for SB. Oquendo et al 42 investigated depressed high-lethality and low-lethality suicide attempters by positron emission tomography (PET) and found decreased metabolic activity in the anterior cingulate gyrus (anterior cingulate cortex [ACC]) and VMPFC in depressed high-lethality suicide attempters. This group difference increased when serotonergic challenge with fenfluramine was carried out. Lower VMPFC activity was associated with the degree of impulsivity and suicidal intent, but not with depression.
The PFC is largely innervated by serotonergic fibers. 43 Serotonergic projections from the DRN to the VMPFC, OFC, and DLPFC are of utmost importance because these frontal brain areas are involved in the executive functions of inhibition and decision making, affective control, and reward processing. Reduced serotonergic input into the VMPFC, OFC, and DLPFC may result in impaired affect regulation as well as in diminished behavioral control and thereby in a greater propensity to act on powerful emotions such as suicidal or aggressive feelings. Thus, both developmental and genetic factors may be responsible for the lower central nervous system serotonergic activity in SB.
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Alterations in brain structure of patients with SB Postmortem studies
Postmortem studies often demonstrated that subjects, who died from suicide, have alterations in the density and size of neuronal and glial cells in the fronto-cingulate brain regions as well as in the serotonin-producing raphe nuclei in the brainstem. Rajkowska et al 45 reported reduced cortical thickness of the OFC in depressed patients due to decreases not only in glial cells but also in neuronal cell density. Additionally, the authors reported a similar reduction in cell density for the DLPFC. Ongur et al 46 reported a considerable reduction of glial cells in the subgenual cingulate cortex in patients with MDD. The major part of the investigated patients in these two studies committed suicide. Mechawar 47 who compared depressed suicide completers to matched natural death controls found hypertrophic white matter fibrous astrocytes in the ACC. In a prior study of this group, altered dendritic branching of the ACC pyramidal neurons was reported in Thus, postmortem studies provided strong evidence for specific morphological alteration in the gray and white matter composition, which might be a consequence of an abnormal serotonergic transmission from DRN to the frontal and anterior cingulate brain regions.
Abnormalities in gray matter
Relatively few in vivo studies have investigated differences in brain structure between patients with and without SB. Ahearn et al 50 reported in a qualitative study based on experts' ratings that depressed patients with SB demonstrated significantly more subcortical gray matter hyperintensities compared with patients without such a history. Monkul et al 51 investigated neuroanatomical differences by means of manual tracing of a priori defined regions-of-interest and detected decreased OFC volumes and increased amygdala volumes in seven depressed patients with a history of suicide attempt. Using voxel-based morphometry (VBM), Aguilar et al 52 reported decreased gray matter volumes in the orbitofrontal and superior temporal cortex in patients with schizophrenia and SB. Giakoumatos et al 53 detected in schizophrenic patients with SB reduced gray matter volume in several cortical regions in the frontal, temporal, and parietal lobes as well as in the thalamus by means of VBM.
Vang et al 54 reported lower volume of caudate nucleus and globus pallidus in suicide attempters, which negatively correlated with serotonin transporter binding potential. Wagner et al 55 have shown by means of VBM that depressed patients with a high risk of suicide (own SB or first-degree relatives with SB) had significantly decreased gray matter density in the ACC and in the caudate nucleus. Dombrovski et al 56 detected lower putamen volumes in older depressed patients with SB.
To ensure better comparability with postmortem studies, Wagner et al 11 used an automated surface-based approach (FreeSurfer) and analyzed differences in the cortical thickness on a node-by-node basis covering the entire cortex. The main finding was that patients with high risk for suicide showed significantly thinner cortex in the left DLPFC and VLPFC as well as in the ACC in contrast to non-high-risk patients. This finding corresponds well with the reduction in neuronal and glial cell size and density in the frontal and anterior cingulate cortices as observed in postmortem studies.
Abnormalities in white matter
With respect to the white matter abnormalities in subjects with SB, Ehrlich et al consistently detected in several studies [57] [58] [59] [60] [61] white matter hyperintensities on T2-weighted magnetic resonance imaging (MRI) images using a modified Coffey rating scale in children, adolescents, and young adults. Recent studies using more sophisticated methods such as diffusion tensor imaging (DTI) detected decreased fractional anisotropy as one parameter of white matter integrity in the left anterior limb of the internal capsule and the right lentiform nucleus in depressed patients with SB. 62 In a recent study, Jia et al 63 observed in line with their previous study a disrupted frontothalamic connectivity in depressed patients with SB in terms of reduced fiber projections through the anterior limb of the internal capsule connecting the left OFC and thalamus. DTI studies of Mahon et al 64 and Olvet et al 65 lend further support to the notion of the abnormal frontal connectivity reporting reduced orbitofrontal fractional anisotropy in the bipolar patients with SB and reduced medial frontal fractional anisotropy in patients with MDD and SB.
A further study revealed a reduced volume of the posterior part of the corpus callosum in elderly patients with MDD (mean age of 72 years) and a history of suicide attempt.
Taken together, findings of abnormal white matter connectivity, predominantly in the fronto-thalamic pathway, corroborate previous structural and postmortem results of reduced prefrontal, anterior cingulate and striatal volume, as well as reduced cortical thickness. Striatal fibers from the ACC project ventrally into the head of caudate in close proximity to the internal capsule. 66 Moreover, the PFC has extensive projections to the striatum via the anterior internal capsule. Thus, these findings provide strong evidence for a potential dysconnectivity in the fronto-striato-thalamic network in patients with SB and might represent a specific neurobiological marker.
Neuroimaging of impulsivity
Genetic effects are believed to act through intermediate phenotypes, 19 which are conceptualized as a mediator between genes and SB. There are considerable data suggesting that impulsive-aggressive personality traits may act as such an intermediate phenotype of SB. 8 Impulsivity can be defined as a function of inhibitory control, and it is understood to be a trait-like phenomenon. 67 Impulsive behavior can be assessed using the Barratt Impulsivity Scale. 68 However, neuropsychological testing based on response inhibition or cognitive inhibition may better quantify this construct. Previous studies using Stroop and stop-signal tasks reported 
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Neural, cognitive, and neuroimaging markers of the suicidal brain a significant relationship between decreased response inhibition and abnormal impulsivity in attention deficit hyperactivity disorder, 69 antisocial personality disorder, 70 and trichotillomania. 71 The serotonergic system is assumed to be strongly involved in impulsivity. 72 For example, serotonin depletion has been found to increase impulsive aggression in men 73 and in women. 74 Functional MRI (fMRI) studies with cognitive inhibition tasks consistently reported activation in a fronto-cingulo-striatal network in healthy subjects. Whereas VLPFC, DLPFC, and striatum as parts of the fronto-basal-ganglia inhibition network are predominately involved in the inhibition of irrelevant motor responses, 75 the function of the ACC has been mainly seen in monitoring potential conflicts and performance adjustment. 76 In light of this, it is an interesting fact that several studies have revealed altered ACC and PFC function in both suicidal and impulsive behavior. Dombrovski et al 77 investigated SB with late-life depression using a reward task. The authors reported decreased pregenual ACC response to high expected reward that was associated with increased impulsivity. Pan et al 78 investigated SB in depressed adolescents by a go-no-go response inhibition and motor control task. The fMRI response revealed reduced ACC activation in the SB group compared with depressive controls. Frankle et al 79 reported reduced 5-HTT availability in the ACC in patients with impulsive aggression compared with healthy subjects in a PET study. Another group investigated patients with borderline personality disorder and impulsive behavior by rCMRglu PET and found bilaterally decreased regional cerebral glucose metabolism in the VMPFC and OFC. 80 Taken together, there is considerable evidence from neuropsychological and neurofunctional studies that both suicidal and impulsive behavior may be accompanied by deficits in cognitive inhibition and behavioral inhibition. These deficits presumably are based on blunted activation of the fronto-striatal network, which is strongly involved in reward processing and behavioral/affective control. The abnormalities observed in this network may constitute the neurobiological basis for an increased predisposition to SB.
Neuroimaging of hopelessness
According to the diathesis-stress model proposed in the present review (Figure 1) hopelessness, besides impulsivity, is a further clinical feature assumed to increase the risk of SB. It is a stable personality trait, which can be measured by the Beck hopelessness scale, a 20-item self-rating inventory. 81 Hopelessness is defined as a system of cognitive schemas encompassing negative expectations about the future, about accomplishing goals, and about the likelihood of achieving success. 81 Hopelessness can be conceptualized as part of negative self-referential processing (ie, thinking). It has been shown to be better correlated with SB than scores at depression rating scales in prospective cohort studies. 82, 83 In a study by van Heeringen et al, 84 the levels of hopelessness were significantly negatively correlated with the 5-HT2A binding index, indicating its association with decreased serotonergic transmission in SB, as is similar for impulsivity.
The majority of neuroimaging studies investigating selfreferential processes found evidence for the strong involvement of cortical midline structures, ie, the posterior cingulate cortex, VMPFC, and dorsomedial PFC during processing of self-related information. 85, 86 van der Meer et al 86 included 20 PET or fMRI studies on self-referential processing in a meta-analysis and found that the VMPFC was a key structure involved in the processing of self-related in contrast to other-related stimuli. In a study of our group, we investigated the neural correlates of self-referential processing in healthy individuals. 87 The main result was that the VMPFC was specifically engaged during negative affective self-referential processing and its activity was significantly related to the degree of depression-like symptoms in participants. Lemogne et al 88 underlined in a recent review the importance of the VMPFC in negative self-referential processing (concept closely related to hopelessness) in MDD and emphasized its putative negative impact on cognitive functions due to aberrant functional connectivity between ACC and VMPFC. Furthermore, recent fMRI studies of Grimm et al 89 and Cooney et al 90 have consistently reported enhanced activation in the VMPFC due to negative self-referential processing.
In summary, these results provide robust evidence for the VMPFC to be a critical brain region for hopelessness and negative self-related processing as well as for the interaction between the self-referential and the "cognitive" brain network in patients with MDD, leading potentially to impaired inhibitory control, ie, an important component of cognitive control.
The search for clinical markers of SB
The assessment of individual suicide risk is difficult for several reasons: 1) Patients may be unwilling or unable to report their intentions. 2) Suicidal acts may occur abruptly. 3) Discrimination of SI and suicidal intent is difficult. 4) There is a low base rate even in high-risk groups. 9 Therefore, it has been argued that a personal history of suicide attempt remains the strongest predictive factor of future suicide. 91, 92 
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Given the comparably weak power of basic clinical assessment, there is a need for additional criteria and tests predicting SB more reliably. In the prior sections, we have underlined the significant role of hopelessness and impulsivity as components of the diathesis for SB. Hopelessness may be assessed with little effort by the Beck hopelessness scale. McMillan et al 82 investigated the ability of the rating scale to predict suicide and nonfatal self-harm by performing a meta-analysis of follow-up studies. The authors reported that the scale measures identified high-risk groups but clinical use in detecting acute suicidality would be unlikely due to low specificity. Other items associated with SB are as follows: high psychological pain, 93 negative life events, 94 childhood adversities, 95 low CSF 5-hydroxyindoleacetic acid and Hypothalamic-pituitary-adrenal axis (HPA) axis dysfunction, 9 serotonin polymorphism (5-HTTLPR), 26 and SI. 96 Unfortunately, none of the latter items is specific enough to allow for reliable prognosis in an individual clinical case. Most risk factors for SB have high sensitivity but comparably poor specificity.
In the search for markers of SB, neurocognitive and neurofunctional approaches appear most promising. According to the well-established impact of impulsivity in SB, neuropsychological studies often reported worse performance on cognitive tasks requiring response inhibition. 97 Moreover, Keilp et al 98 found impaired inhibition processes during Stroop task in depressed patients with SB compared to depressed patients without SB. Becker et al 99 as well as Williams and Broadbent 100 observed in suicide attempters impaired response inhibition in an emotional Stroop task with suicide-related words. Cha et al 101 reported that suicidespecific attentional bias in the emotional Stroop task predicted above and beyond other clinical predictors who completed a suicide attempt within the next 6 months. Nock et al 10 reported that implicit cognition of death and suicide as measured by a computer-administered neurocognitive paradigm exceeded the predictive validity of all known risk factors (eg, depression, suicide-attempt history) and both patients' and clinicians' predictions. We suggest that measures of implicit cognition -if results are replicated in larger future studiesmay be useful as a behavioral marker of SB.
Even more precise estimates may become possible by the use of functional and structural neuroimaging approaches and the rising number of specific circumscribed findings as depicted in previous sections. For example, with regard to potential neurofunctional markers, Willeumier et al 12 investigated patients with mood disorders scanned previously by single photon emission computed tomography (SPECT) who completed suicide. The authors reported decreased regional cerebral blood flow (rCBF) in the subgenual ACC in 18 of the 21 subjects. Additionally, blood perfusion was decreased in the DLPFC. Regarding potential structural markers, Wagner et al 11 investigated prefrontal cortical thickness in depressed patients with a high risk for SB. The main finding was that patients with a high risk for suicide showed significantly thinner cortex in the left DLPFC and VLPFC as well as in the ACC in contrast to non-high-risk patients (Figure 2) . Thus, these functional and structural deficits may represent a neurobiological marker of SB, which may be directly related to reported deficits in emotional, cognitive, and behavioral control. If these findings can be replicated in larger samples by future studies, they possibly may be used as clinical markers for SB in psychiatric patients. However, a clinical strategy for predicting acute suicidality should be based on both trait-like characteristics such as neurobiological or behavioral markers and state-dependent stressors induced by psychiatric illness and psychosocial crises.
Discussion
SB represents a major health problem worldwide. Although SB occurs in association with MDD or other psychiatric disorders, there is evidence from genetic studies that it might represent a psychiatric disorder on its own. In nosological discussions during preparation of the Diagnostic and Statistical Manual of Mental Disorders, it has been proposed to create a separate diagnostic category for SB that should be documented on a sixth axis. 102 At the end of this process, an agreement was reached about including "suicidal behavior disorder" as a "condition for further study". 103 This review aimed to give a concise overview of the most significant neurobiological findings in SB. We provided evidence for specific dysfunctions within the serotonergic system, for distinct morphological abnormalities in the gray and white matter composition as well as for neurofunctional alterations in the fronto-striatal network.
In summary, neurochemical studies have often demonstrated abnormal serotonergic transmission in SB. In contrast, no consistent changes regarding dopaminergic or noradrenergic transmission were detected. A number of studies have focused on neurochemical indices in several areas of the frontal cortex, which is largely innervated by serotonergic projections from the DRN and MRN. The reported observations might imply an abnormal serotonergic modulation of the medial and lateral frontal brain areas, eg, VMPFC and DLPFC. The VMPFC/OFC and DLPFC are of eminent importance due to the involvement in 
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Sobanski et al the frontal, cingulate, and striatal brain regions as well as directly in the serotonin-producing raphe nuclei in the brainstem. With regard to white matter, abnormalities in the fronto-striatal connectivity have been found in SB by DTI studies. These results corroborate previous structural and postmortem findings of reduced frontal, cingulate, and striatal volume and provide strong evidence for a potential dysconnectivity in the fronto-striatal network in patients with SB. According to the proposed diathesis-stress model, impulsivity and hopelessness are risk factors or trait-like components of the diathesis for SB. Both conditions may be accompanied by deficits in cognitive and affective control similar to the findings in SB. In impulsivity and SB, these deficits presumably are based on blunted activation of the fronto-striatal network, which is strongly involved in behavioral/affective control and reward processing. With regard to hopelessness and self-referential processing, the VMPFC appears to be a critical brain region due to the interaction between the self-referential and the "cognitive" brain network.
In consideration of the different methods applied in previous studies as well as small sample sizes, we tentatively concluded that the neurochemical as well as structural and functional neuroimaging findings converge at a point which implicates altered serotonergic neurotransmission and abnormal frontal cortical structure and function to be of major significance in SB.
Nevertheless, in our opinion at present many issues remain unresolved. Despite the relatively consistent evidence of an association between SB and alterations in the fronto-striatal network, the present literature reveals a lack of knowledge with regard to the functional interplay within this network and its relationship to psychopathology. Up to date, no study has investigated the neural correlates of the postulated "traits" in SB, ie, impulsivity and hopelessness with appropriate neurocognitive and neurofunctional paradigms. Furthermore, the functional interplay between DRN and the fronto-striatal network in patients with SB has not been studied yet. Additionally, a combined analysis of function and structure in patients with SB has not been performed yet -for answering the open question -whether and to what extent structural alterations are related to changes in functional activation and functional or effective connectivity. Hopefully, these complex questions will be addressed in the future by strategic multimodal investigations.
In conclusion, the clinical assessment of individual suicide risk remains difficult. Thus, there is a need to find specific markers, which predict SB more reliably than currently available. Some recent neurocognitive and functional/structural neuroimaging findings might be appropriate for use as clinical indicators of SB within the near future. However, a clinical strategy for detection and timely treatment of acute suicidality should be based on both traitlike characteristics such as behavioral and neurobiological markers and state-dependent stressors such as psychiatric illness or psychosocial crises. Closely related to the treatment of SB is the issue of its prevention. Considering the huge human tragedy and the high economical costs for societies caused by SB, 104 some countries have developed national suicide-prevention plans. Mann et al 105 examined various suicide-preventive interventions and concluded that there is evidence for the effectiveness of only two prevention strategies: improving education of physicians in depression recognition and treatment as well as restricting access to lethal methods.
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